SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Microcide Pharmaceuticals (MCDE)
An SI Board Since October 1996
Posts SubjectMarks Bans Symbol
186 7 0 MCDE
Emcee:  Gary M. Reed Type:  Unmoderated
Introduction Market Data Compact
MCDE is focusing on the problem of antibiotic-resistant bacteria. The lack of new antibiotic drug classes in the past two decades has lead to widespread bacterial resistance. MCDE has targeted 4 types of bacteria which account for 44% of all hospital-acquired infections. They have several promising candidates in their pipeline, and have development agreements with JNJ/Ortho, Daiichi Pharmaceuticals, and Pfizer.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
186159Tummus1-5/28/2003
185incredibly well-written........ Message 15730667scaram(o)uche-4/29/2001
184no biggie, was just cruising this site and thought that others might not know abscaram(o)uche-12/19/2000
183iconixpharm.comscaram(o)uche-8/17/2000
182 sudden intraday reversal -- on low volume, however -- was looking at it, wonderscaram(o)uche-6/27/2000
181 What is behind recent rise? My bet is we picked up one or two tiny stock-letteNikole Wollerstein-9/7/1999
180 Richard; What is your opinion as to MCDE prospects to be in the front of the paSteve Lokness-9/2/1999
179 Moscone, San Francisco (eom) scaram(o)uche-9/2/1999
178 Hi, Richard: Thanks for posting abstracts. Where will be the conference? Nikole Wollerstein-9/2/1999
177 Richard...I read that MCDE had something on the order of 17 posters/papers to pLarry Liebman-8/29/1999
176 Session: Pharmacodynamic Studies of Drug-resistant Bacteria (with scaram(o)uche-8/29/1999
175 [sorry, can't get table to cut and paste] Session: Pharmacodynamics and Efscaram(o)uche-8/29/1999
174 Session: Inhibitors of Bacterial and Fungal Efflux Pumps scaram(o)uche-8/29/1999
173 Session: Inhibitors of Bacterial and Fungal Efflux Pumps scaram(o)uche-8/29/1999
172 Session: Inhibitors of Bacterial and Fungal Efflux Pumps scaram(o)uche-8/29/1999
171 sorry, I can't get the table to cut and paste...... Session: Inhibitors ofscaram(o)uche-8/29/1999
170 Session: Inhibitors of Bacterial and Fungal Efflux Pumps scaram(o)uche-8/29/1999
169 Session: Inhibitors of Bacterial and Fungal Effluxscaram(o)uche-8/29/1999
168 Session: Inhibitors of Bacterial and Fungal Efflux Pumps scaram(o)uche-8/29/1999
167 Session: Inhibitors of Bacterial and Fungal Efflux Pumps scaram(o)uche-8/29/1999
166 Session: Novel b-Lactams and b-Lactamase Inhibitors Loscaram(o)uche-8/29/1999
165 Session: Novel b-Lactams and b-Lactamase Inhibitors scaram(o)uche-8/29/1999
164 Session: Novel b-Lactams and b-Lactamase Inhibitors scaram(o)uche-8/29/1999
163exchange2000.comscaram(o)uche-1/25/1999
162 Interesting tidbit- <I>New antibiotic shows promise Human testing plannMark Adams-5/18/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News